Retour aux projets

15705.1;7 PFLS-LS

Novel therapy against red blood cell diseases through blocking of calcium uptake

Résumé

Novel therapy against red blood cell diseases through blocking of calcium uptake

Textes supplémentaires

Abstract

We plan to use memantine for targeting NMDA receptors in red blood cells of patients with sickle cell disease in vivo. We envison reduction of hemolysis and in the vasooclusive crises. The answer we seek is whether memantine is well-tolerated by sickle cell disease patients. We aim to set ground for a bigger trial and market the compound for new hematological applications and to use NMDA receptors in red blood cells as a pharmacological target.

Participants

Max Gassmann

Kontaktperson

Universität Zürich Max Gassmann Winterthurerstrasse 260 8057 Zürich ZH CH

Détails du projet

Office de recherche
INNOSUISSE
Statut du projet
Abgeschlossen
Type de projet
Forschungsprojekt
Date de début
2013-06-30
Date de fin
2014-06-28
Coûts totaux approuvés
CHF 25000.00
Section
20 Förderbereich Life Sciences
Domaine politique NABS
Nicht aufteilbare / nicht zuteilbare Forschung

Disciplines de recherche

  • T490 Biotechnology 100.0%